Anti-tenascin-C A2 antibodies and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9156913
APP PUB NO 20120039807A1
SERIAL NO

13207705

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides antibodies against the A2 domain of tenascin-C and methods of using the same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE GLYCART AGSCHLIEREN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Freimoser-Grundschober, Anne Zurich, CH 60 883
Hosse, Ralf Cham, CH 86 1599
Klein, Christian Bonstetten, CH 571 9941
Moessner, Ekkehard Kreuzlingen, CH 194 2920
Nicolini, Valeria G Erlenbach, CH 31 478
Umaña, Pablo Waedenswil, CH 95 705

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 13, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00